SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Tailored Bacterial Magnetic Nanoparticles For Biomedical Imaging

This project aims to revolutionize biomedical applications by developing high-quality, biocompatible magnetic iron oxide nanoparticles using genetically engineered microbes for enhanced functionality and sustainability.

Subsidie
€ 150.000
2023

Projectdetails

Introduction

Of tremendous biomedical and clinical interest are magnetic iron oxide nanoparticles (MNP) that can be tailored to fulfill specific functions, for instance as actuated drug carriers, tracers for magnetic imaging modalities, or heat generators in magnetic hyperthermia for cancer therapy.

Challenges in Current Applications

However, their use in real-world applications has been hampered by:

  • Lack of precise size control and magnetic tunability
  • Poor biocompatibility associated with their conventional synthesis

Proposed Solution

I propose a step-change approach for the light-powered bioproduction of high-quality magnetic nanoparticles by novel synthetic microbes generated in ERC-AdG Syntomagx, crafted precisely for their use in biomedical applications.

Advantages of Novel Bacterial MNP

Compared to commercial, chemically synthesized MNP, these novel bacterial MNP are expected to exhibit superior applicability and versatility, owing to:

  1. Genetically tuned and uniform physicochemical and magnetic characteristics
  2. High cost-efficiency
  3. Sustainable manufacturing conditions

Production and Assessment

First, bacterial production and purification of the particles will be set up at large lab scale. In addition, their anticipated superior biocompatibility will be thoroughly assessed.

Collaboration and Demonstration

Then, we will explore and demonstrate their performance in collaboration with various biomedical end users. As proof-of-concept, we will deliver a formulation of bacterial MNP tailored as potent tracers in high-resolution magnetic particle imaging (MPI).

Long-term Goals

With respect to the long-term goal of future commercial exploitation, we will explore patenting options and thoroughly assess the demand for such high-quality biogenic MNP.

Vision for the Future

I envision that our idea will revolutionize the biomedical MNP market by opening it for the wealth of genetically tailored and highly functionalized bacterial MNP, suitable for a wide range of applications.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-11-2023
Einddatum30-4-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UNIVERSITAT BAYREUTHpenvoerder

Land(en)

Germany

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Nano-Biological Contrast Agent Platform for MRI Imaging

NANO-IMAGING aims to develop customizable, safe, and tissue-specific MRI contrast agents using metal-protein hybrid nanostructures to enhance diagnostic imaging efficiency.

ERC Proof of...€ 150.000
2022
Details

MAGNETIC HYPERTHERMIA FOR METASTASIZED TUMOR TREATMENT AND REMOTE MANIPULATION OF MICRODEVICES

The GIULIa project aims to enhance cancer treatment by using magnetic nanoparticles in natural killer cells for targeted hyperthermia and developing magnetic microdevices for precise drug delivery.

ERC Consolid...€ 2.993.750
2023
Details

MAGNIFICO-Pre-commercialization of multifunctional targeted MRI-contrast enhancing agents for brain research

This project aims to enhance MRI's capabilities for brain disease research by developing targeted fluorescent contrast agents and engineering cells for improved in vivo imaging.

ERC Proof of...€ 150.000
2022
Details

Bulk rare earth free permanent magnets

The project aims to develop a high-performance, rare-earth-free MnBi permanent magnet using a novel processing route for large-scale industrial applications, enhancing temperature stability and energy efficiency.

ERC Proof of...€ 150.000
2022
Details

A companion magnetic sensor for in operando detection of magnetic biosynthesis in cancer and neurodegenerative models

The BioMag PoC project aims to develop a sensitive magnetic sensor for real-time monitoring of intracellular magnetic iron biosynthesis, potentially leading to novel therapies for cancer and Alzheimer's.

ERC Proof of...€ 150.000
2022
Details
ERC Proof of...

Nano-Biological Contrast Agent Platform for MRI Imaging

NANO-IMAGING aims to develop customizable, safe, and tissue-specific MRI contrast agents using metal-protein hybrid nanostructures to enhance diagnostic imaging efficiency.

ERC Proof of Concept
€ 150.000
2022
Details
ERC Consolid...

MAGNETIC HYPERTHERMIA FOR METASTASIZED TUMOR TREATMENT AND REMOTE MANIPULATION OF MICRODEVICES

The GIULIa project aims to enhance cancer treatment by using magnetic nanoparticles in natural killer cells for targeted hyperthermia and developing magnetic microdevices for precise drug delivery.

ERC Consolidator Grant
€ 2.993.750
2023
Details
ERC Proof of...

MAGNIFICO-Pre-commercialization of multifunctional targeted MRI-contrast enhancing agents for brain research

This project aims to enhance MRI's capabilities for brain disease research by developing targeted fluorescent contrast agents and engineering cells for improved in vivo imaging.

ERC Proof of Concept
€ 150.000
2022
Details
ERC Proof of...

Bulk rare earth free permanent magnets

The project aims to develop a high-performance, rare-earth-free MnBi permanent magnet using a novel processing route for large-scale industrial applications, enhancing temperature stability and energy efficiency.

ERC Proof of Concept
€ 150.000
2022
Details
ERC Proof of...

A companion magnetic sensor for in operando detection of magnetic biosynthesis in cancer and neurodegenerative models

The BioMag PoC project aims to develop a sensitive magnetic sensor for real-time monitoring of intracellular magnetic iron biosynthesis, potentially leading to novel therapies for cancer and Alzheimer's.

ERC Proof of Concept
€ 150.000
2022
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Single Molecule Nuclear Magnetic Resonance Microscopy for Complex Spin Systems

This project aims to enhance NMR sensitivity to single molecules using scanning probe microscopy, enabling groundbreaking insights in nanotechnology and impacting NMR and SPM markets.

EIC Pathfinder€ 2.994.409
2023
Details

A synaptic mechanogenetic technology to repair brain connectivity

Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.

EIC Pathfinder€ 3.543.967
2023
Details

Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infections

LeadToTreat aims to develop targeted nano-formulations for treating MRSA infections by co-delivering novel low-drugability compounds and synergistic antibiotic combinations.

EIC Pathfinder€ 2.665.564
2022
Details

MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation

META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.

EIC Pathfinder€ 2.987.655
2024
Details

NanoBiCar: A novel immunotherapy for infectious diseases

NanoBiCar aims to revolutionize bacterial infection treatment through innovative mRNA-based immunotherapy, targeting Mycobacterium tuberculosis to eliminate drug-resistant strains without generating resistance.

EIC Pathfinder€ 2.999.101
2025
Details
EIC Pathfinder

Single Molecule Nuclear Magnetic Resonance Microscopy for Complex Spin Systems

This project aims to enhance NMR sensitivity to single molecules using scanning probe microscopy, enabling groundbreaking insights in nanotechnology and impacting NMR and SPM markets.

EIC Pathfinder
€ 2.994.409
2023
Details
EIC Pathfinder

A synaptic mechanogenetic technology to repair brain connectivity

Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.

EIC Pathfinder
€ 3.543.967
2023
Details
EIC Pathfinder

Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infections

LeadToTreat aims to develop targeted nano-formulations for treating MRSA infections by co-delivering novel low-drugability compounds and synergistic antibiotic combinations.

EIC Pathfinder
€ 2.665.564
2022
Details
EIC Pathfinder

MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation

META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.

EIC Pathfinder
€ 2.987.655
2024
Details
EIC Pathfinder

NanoBiCar: A novel immunotherapy for infectious diseases

NanoBiCar aims to revolutionize bacterial infection treatment through innovative mRNA-based immunotherapy, targeting Mycobacterium tuberculosis to eliminate drug-resistant strains without generating resistance.

EIC Pathfinder
€ 2.999.101
2025
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.